MedPath
NMPA Approval

Aliskiren Tablets

国药准字HC20191005

February 2, 2021

HC20191005

Drug Information

阿利吉仑片

锐思力

片剂

300mg(以阿利吉仑计)

化学药品

February 2, 2021

February 1, 2026

Company Information

Applicant Company

11F., No.36, Songren Rd., Xinyi dist., Taipei City 110, Taiwan(R.O.C)

Manufacturing Company

novartis farma s.p.a

Via Provinciale Schito, 131 80058 Torre Annunziata(NA), Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿利吉仑片 - NMPA 批准文号 | MedPath